U.S. Senate leadership reportedly has reduced the proposed levy on medical device makers in the health reform bill from $40 billion to between $15 billion and $20 billion over 10 years, according to a report by the Wall Street Journal.
The lower fee comes as big device makers lobbied hard against the proposed $40 million fee, enlisting senators in their home states of Minnesota, California, Massachusetts and elsewhere.
The original reform bills in the U.S. House did not have a device fee, but House Democrats are now devising an excise tax on medical devices, to be paid at the point of sale, that would yield a total of $20 billion between 2013 and 2019.
Read the Wall Street Journal’s report on the proposed medical device fee.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.